The San Diego office of Morrison & Foerster LLP represented Santa Barbara-based Inamed Corp. in a $2.8 billion merger with Scottsdale, Ariz.-based Medicis Pharmaceutical Corp.
Inamed, listed on the Nasdaq as IMDC, and Medicis, listed on the New York Stock Exchange as MRX, announced March 21 that they have entered into a definitive merger agreement to create a global leader in breast and facial aesthetics products and therapeutic dermatological medicine.
The combined company will have annual revenue in excess of $700 million, operations in more than 12 countries, businesses in more than 60 countries, and approximately 1,500 employees.
Morrison & Foerster’s San Diego corporate group has served as counsel in 18 merger-and-acquisition transactions over the last two years.
The companies expect the transaction to close by the end of calendar 2005.